Simplifying Global Compliance
FDAnews Drug Daily Bulletin
J&J Appoints Gorsky CEO as Company Seeks Stability After Recall Concerns
Feb. 23, 2012
Johnson & Johnson (JNJ)’s insider pick of Alex Gorsky as the new chief executive officer elevates the person most familiar with the safety and quality issues that have plagued the company.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing